Yayın:
Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSabina Yasmin
dc.contributor.authorBAYSAL, MERVE
dc.contributor.authorFabio Capone
dc.contributor.authorAtlı, Özlem
dc.contributor.authorAntonio Laghezza
dc.contributor.authorFabrizio Dal Piaz
dc.contributor.authorFulvio Loiodice
dc.contributor.authorV. Viswanathan
dc.contributor.authorD. Velmurugan
dc.contributor.authorSusanta Mondal
dc.contributor.authorÖzlem Atlı
dc.contributor.authorMerve Baysal
dc.contributor.authorAshok Pattnaik
dc.contributor.authorVenkatesan Jayaprakash
dc.contributor.authorAntonio Lavecchia
dc.contributor.orcid0000-0001-8399-1230
dc.contributor.orcid0000-0003-4909-1145
dc.contributor.orcid0000-0001-6221-6155
dc.contributor.orcid0000-0002-8643-5018
dc.contributor.orcid0000-0003-3384-574X
dc.contributor.orcid0000-0001-7178-5966
dc.contributor.orcid0000-0001-6465-9769
dc.contributor.orcid0009-0005-9505-0565
dc.contributor.orcid0000-0002-8099-0942
dc.contributor.orcid0000-0003-2931-9042
dc.contributor.orcid0000-0002-9724-4153
dc.contributor.orcid0000-0002-2181-8026
dc.date.accessioned2025-11-13T09:29:55Z
dc.date.issued2017-10-25
dc.identifier.doi10.1038/s41598-017-14776-0
dc.identifier.endpage14453
dc.identifier.issn2045-2322
dc.identifier.issue1
dc.identifier.openalexW2765770941
dc.identifier.pubmed29089569
dc.identifier.scopus2-s2.0-85032638225
dc.identifier.startpage14453
dc.identifier.urihttps://hdl.handle.net/11421/1325
dc.identifier.urihttps://doi.org/10.1038/s41598-017-14776-0
dc.identifier.volume7
dc.identifier.wos000414231000054
dc.language.isoen
dc.relation.ispartofScientific Reports
dc.rightsopenAccess
dc.subjectThiazolidinedione
dc.subjectRosiglitazone
dc.subjectChemistry
dc.subjectGlucose homeostasis
dc.subjectNuclear receptor
dc.subjectPeroxisome proliferator-activated receptor
dc.subjectReceptor
dc.subjectDiabetes mellitus
dc.subjectPharmacology
dc.subjectSurface plasmon resonance
dc.subjectInternal medicine
dc.subjectEndocrinology
dc.subjectType 2 diabetes
dc.subjectBiochemistry
dc.subjectMedicine
dc.subjectInsulin resistance
dc.subjectTranscription factor
dc.subjectMaterials science
dc.subjectNanotechnology
dc.subject.sdg3
dc.titleNovel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5027386527
local.authorid.openalexA5110553744

Dosyalar

Koleksiyonlar

Publications